Dusseldorf - Delayed Quote EUR
Geron Corp (GON.DU)
1.2240
+0.0820
+(7.18%)
At close: April 23 at 7:30:58 PM GMT+2
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
GON.DU | -- | -- | -- | -- |
S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
Reiterates | Needham: Buy to Buy | 3/12/2025 |
Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/12/2025 |
Maintains | Scotiabank: Sector Outperform to Sector Outperform | 2/27/2025 |
Maintains | Stifel: Buy to Buy | 2/27/2025 |
Maintains | Barclays: Overweight to Overweight | 2/27/2025 |
Maintains | Needham: Buy to Buy | 2/27/2025 |
Related Tickers
HTD.MU Corcept Therapeutics Inc
56.94
+3.98%
BT3.BE Lineage Cell Therapeutics Inc
0.3720
+10.71%
0M4.DU Mersana Therapeutics Inc
0.3381
+4.87%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
50BA.F Bicycle Therapeutics plc
7.60
+16.92%
300759.SZ Pharmaron Beijing Co., Ltd.
23.41
+3.04%
PI3.DU Gubra AS
48.22
+4.64%
PL3.F TuHURA Biosciences, Inc.
3.5800
+2.29%
FLERIE.ST Flerie AB (publ)
40.26
-0.62%
GNRO.PA GeNeuro SA
0.0780
+5.41%